BARRY SHINSEL: Open Payments
NPI 1144930801 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 11 payments from 7 companies in 2025. Trend: 2023 $209 · 2024 $96 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| ABBVIE INC. | 3 | $53 |
| GENZYME CORPORATION | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: ENTYVIO, DUPIXENT, RINVOQ, VOWST, EOHILIA, MAVYRET, VOQUEZNA.
Industry payments across ID — which companies pay providers there.
